| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9814 | 
      | Human Intestinal Absorption | HIA+ | 0.9862 | 
      | Caco-2 Permeability | Caco2- | 0.5087 | 
      | P-glycoprotein Substrate | Substrate | 0.6315 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.6518 | 
                                                     | Inhibitor | 0.5991 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.6706 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6973 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8848 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.5000 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5714 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.8906 | 
      | CYP450 2C9 Inhibitor | Inhibitor | 0.6520 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.8377 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.5372 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8033 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9223 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.5443 | 
                                                                    | Inhibitor | 0.8653 | 
      | AMES Toxicity | Non AMES toxic | 0.9133 | 
      | Carcinogens | Non-carcinogens | 0.8876 | 
      | Fish Toxicity | Low FHMT | 0.6224 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9775 | 
      | Honey Bee Toxicity | Low HBT | 0.9229 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | II | 0.7458 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5637 |